Moderna (MRNA) is a publicly traded Healthcare sector company. As of October 4, 2026, MRNA trades at $189.57 with a market cap of $75.86B and a P/E ratio of -23.76. MRNA moved +0.55% today. Year to date, MRNA is +515.72%; over the trailing twelve months it is +569.76%. Its 52-week range spans $22.28 to $208.90. Analyst consensus is neutral with an average price target of $107.29. Rallies surfaces MRNA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
20 analysts cover MRNA: 0 strong buy, 3 buy, 15 hold, 2 sell, and 0 strong sell. The consensus rating is neutral. The average price target is $107.29.
| Metric | Value |
|---|---|
| Price | $189.57 |
| Market Cap | $75.86B |
| P/E Ratio | -23.76 |
| EPS | $-7.98 |
| Dividend Yield | 0.00% |
| 52-Week High | $208.90 |
| 52-Week Low | $22.28 |
| Volume | 9.66M |
| Avg Volume | 0 |
| Revenue (TTM) | $2.23B |
| Net Income | $-3.15B |
| Gross Margin | 23.38% |
20 analysts cover MRNA: 0 strong buy, 3 buy, 15 hold, 2 sell, 0 strong sell. Consensus rating is neutral. Average price target: $107.29.